Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and ChemotherapyNeoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenoma, epithelial neoplasm, lung disorder, lung neoplasm, malignant mesothelioma, mesothelial neoplasm, mesothelioma, neoplasm, pleural neoplasm, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-08-10NCT06840834

2 results · Page 1 of 1

Swipe the table sideways for more columns.

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Besançon - CHUBesançonFrance7
Bordeaux - CHUPessacFrance7
Brest - CHUBrestFrance5
Caen - CHUCaenFrance6
Centre Leon BerardLyonFrance34
Clermont-Ferrand - Centre Jean PerrinClermont-FerrandFrance2
Créteil - CHICréteilFrance6
Grenoble - CHUGrenobleFrance7
Le Mans - CHGLe MansFrance10
Lille - CHULilleFrance4
Lyon - HCLPierre-BéniteFrance4
Marseille - APHMMarseilleFrance6
Metz - Hôpital Robert SchumanVantouxFrance1
Montpellier - CHUMontpellierFrance6
Mulhouse - GHRMSAMulhouseFrance5
Nantes - Hôpital LaennecNantesFrance2
Paris - BichatParisFrance4
Strasbourg - Nouvel Hôpital CivilStrasbourgFrance2
Toulon - CHIToulonFrance4
Toulouse - CHUToulouseFrance6
Tours - CHUToursFrance6